Product Information
TOBRAMYCIN 300 MG/5 ML AMPULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.0917 per ML under NDC 00093408563. Its NADAC has been published 545 times since Nov 18, 2015.
Strength
300 mg/5mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093408563
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA091589On Market Since
11/19/2013
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has been published 545 times since Nov 18, 2015, and over the history we have for it it has declined 92.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0917 per ML |
|---|---|
| All-time high | $14.2842 (Dec 16, 2015) |
| All-time low | $1.0672 (Mar 18, 2026) |
| 52-week high | $1.7603 |
| 52-week low | $1.0672 |
| Median price | $4.6175 |
| Average price | $5.3136 |
| Largest weekly change | -33.9% (Nov 20, 2024) |
| Weeks tracked | 545 |
| Tracking since | Nov 18, 2015 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 300 MG/5 ML AMPULE?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 300 MG/5 ML AMPULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.0917 per ML (NDC 00093408563), effective Jun 24, 2026.
How has the price of TOBRAMYCIN 300 MG/5 ML AMPULE changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has declined 92.4%. It has been tracked across 545 weekly CMS publications since Nov 18, 2015.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 300 MG/5 ML AMPULE?
Since Nov 18, 2015, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has ranged from a low of $1.0672 (Mar 18, 2026) to a high of $14.2842 (Dec 16, 2015), with a median of $4.6175 per ML.
Are there cheaper alternatives to TOBRAMYCIN 300 MG/5 ML AMPULE?
7 NADAC-published products share the same active ingredient, strength, and dosage form as TOBRAMYCIN 300 MG/5 ML AMPULE, but none are currently priced below it.
Who manufactures TOBRAMYCIN 300 MG/5 ML AMPULE?
TOBRAMYCIN 300 MG/5 ML AMPULE (NDC 00093408563) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification